Improving MRI techniques for prostate cancer imaging
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
This study is testing new MRI techniques to see if they can improve how doctors find and monitor prostate cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 2 sites (Scottsdale, Arizona and 1 other locations) |
| Trial ID | NCT06315595 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates various technological advancements in MRI to enhance the performance of contrast-enhanced imaging used for angiography and perfusion, as well as non-contrast MRI. Participants will undergo non-contrast MRI scans, with the option for a second scan, and may also provide blood samples for analysis. The goal is to determine if these improvements can lead to better imaging outcomes for prostate neoplasm diagnosis and monitoring.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who require MRI imaging for prostate neoplasm evaluation.
Not a fit: Patients with contraindications for MRI, such as those with certain implanted devices or severe claustrophobia, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and safer imaging techniques for patients with prostate cancer.
How similar studies have performed: Other studies have shown promise in improving MRI techniques, but this specific approach is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults Exclusion Criteria: * Standard exclusion criteria for clinical MRI; e.g. cardiac pacemaker, claustrophobia, an implanted device that has been determined to be MR conditional at 1.5T but not at 3T, anticipated considerable susceptibility artifact from hip prosthesis, etc.
Where this trial is running
Scottsdale, Arizona and 1 other locations
- Mayo Clinic in Arizona — Scottsdale, Arizona, United States (Active_not_recruiting)
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Stephen J. Riederer, PhD — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.